NRSNW Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020	FY-2019
Period Ended	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Operating Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Cost of Revenue	$97,000.00	$89,000.00	$3,000.00	$3,000.00	$0.00
Gross Profit	-$97,000.00	-$89,000.00	-$3,000.00	-$3,000.00	$0.00
Gross Profit Ratio	0	0	0	0	0
Research and Development Expenses	$7.59 M	$6.42 M	$3.08 M	$2.50 M	$898,000.00
General & Administrative Expenses	$5.71 M	$7.14 M	$2.51 M	$393,000.00	$337,000.00
Selling & Marketing Expenses	$5.61 M	$0.00	$0.00	$0.00	$0.00
Selling, General & Administrative Expenses	$5.62 M	$7.14 M	$2.51 M	$393,000.00	$337,000.00
Other Expenses	$0.00	$0.00	$0.00	$0.00	$0.00
Operating Expenses	$13.21 M	$13.55 M	$5.59 M	$2.89 M	$1.24 M
Cost And Expenses	$13.30 M	$13.55 M	$5.59 M	$2.89 M	$1.24 M
Interest Income	$178,000.00	$91,000.00	$0.00	$61,000.00	$18,000.00
Interest Expense	$550,000.00	$15,000.00	$1.15 M	$1,000.00	$5,000.00
Depreciation & Amortization	$97,000.00	$173,000.00	-$2.70 M	$64,000.00	-$18,000.00
EBITDA	-$13.21 M	-$13.38 M	-$8.28 M	-$2.82 M	-$1.25 M
EBITDA Ratio	0	0	0	0	0
Operating Income	-$13.30 M	-$13.55 M	-$5.59 M	-$2.89 M	-$1.24 M
Operating Income Ratio	0	0	0	0	0
Total Other Income/Expenses Net	$2.02 M	$1.21 M	$1.55 M	$60,000.00	$13,000.00
Income Before Tax	-$11.28 M	-$12.34 M	-$4.04 M	-$2.83 M	-$1.22 M
Income Before Tax Ratio	0	0	0	0	0
Income Tax Expense	-$1.00	-$1.14 M	-$1.55 M	$1,000.00	$5,000.00
Net Income	-$11.28 M	-$11.20 M	-$2.50 M	-$2.83 M	-$1.23 M
Net Income Ratio	0	0	0	0	0
EPS	-0.83	-0.97	-1.29	-1.46	-0.63
EPS Diluted	-0.83	-0.97	-1.29	-1.46	-0.63
Weighted Average Shares Out	$13.64 M	$11.50 M	$1.94 M	$1.94 M	$1.94 M
Weighted Average Shares Out Diluted	$13.64 M	$11.50 M	$1.94 M	$1.94 M	$1.94 M
Link

NeuroSense Therapeutics Ltd. (NRSNW) Financials

Select an alert type

Setup alert

Log In

Email Verification

Welcome to StockNews!

Create Your Account

Email Verification